Lihua Wang

My current research integrates cutting-edge platforms including mRNA technologies, single B cell antibody discovery, and viral vector-based delivery to address critical threats such as African swine fever, rabies, canine distemper, parvovirus, feline infectious peritonitis, and antimicrobial resistance. In collaboration with the Center on Biologics Development and Evaluation (CBDV) at Kansas State University, I am actively engaged in bridging laboratory innovation with real-world application.